Objective: The present study aims to establish the oxidant/antioxidant status in serum samples from pregnant women above the threshold for Down syndrome risk according to the quadruple test.
INTRODUCTION
Down syndrome (DS) is a chromosomal disorder caused by the trisomy, translocation or mosaicism of chromosome 21 in humans. It appears in about 1 of every 700 live births and is the most frequent genetic cause of mental retardation (1, 2) . DS patients often have cardiac malformations, premature aging, cataracts, and growth retardation (3) . Although the exact mechanism underlying DS is far from clear, over-expression of genes located in the 21 st chromosome resulting loss of chromosomal balance is considered to be determinant for DS phenotype (3, 4) . The gene for Cu/Zn superoxide dismutase (SOD, EC 1.15.1.1), as an antioxidant enzyme, is known to be located on the long arm of the 21 st chromosome (4) . It has been demonstrated that SOD activity is increased in the serum samples of women carrying a DS affected fetus (5) . It has also been found that oxidant stress markers, including increased protein and lipid peroxidation, decreased glutathione (GSH) and thioredoxin levels, and induction of heat shock protein response, increased in amniotic fluids of pregnant women carrying DS affected fetuses (2) . Increased SOD activity not compensated by glutathione peroxidase (GSH-Px, EC 1.11.1.9) and catalase (EC 1.11.1.6) activities may lead to oxidative imbalance (6) .
There are prenatal screening tests to determine the risk for carrying DS affected fetuses. The quadruple test, one of the prenatal screening tests, calculates the fetal DS risk at term from maternal age at term and the concentration of four markers in maternal serum, namely alphafetoprotein (AFP), unconjugated estriol (uE 3 ), human chorionic gonadotropin (hCG) and inhibin-A, at 14-22 weeks of gestation (7).
Oxidative stress occurs when there is an imbalance between oxidant agents and antioxidant mechanisms. Free radical is a species which has one or more unpaired electrons and is known as an oxidant agent (8) . Malondialdehyde (MDA), the lipid peroxidation end product, is one of the markers for oxidative stress (9) . Superoxide, a free radical, is converted to H 2 O 2 by SOD, and GSH-Px is an enzyme that plays a role in the reduction of H 2 O 2 to water (10) .
There are also non-enzymatic factors playing a role in the scavenging of superoxide known as non-enzymatic superoxide radical scavenger activity (NSSA) (11) .
To the best of our knowledge, there is no study yet in the literature investigating the relation between maternal oxidant/antioxidant status and DS risk provided by the prenatal screening tests. For this reason, this study aimed to establish oxidant/antioxidant status in serum samples from pregnant women above threshold for DS risk at term according to the quadruple test. It was also aimed to determine the differences in oxidant/antioxidant status between low and high risk pregnancies for DS. (14) .
MATERIALS AND METHODS
For the evaluation of the oxidant/antioxidant status, MDA levels (oxidant parameter) and GSH-Px enzyme activities and NSSA (antioxidant parameters) were measured in the stored serum samples from the pregnant women. MDA level (µmol/L) was measured by the thiobarbituric acid reactive substances (TBARS) method (15) . GSH-Px activity (IU/L) was measured by following the changes in reduced form of nicotinamide adenine dinucleotide phosphate (NADPH) absorbance at 340 nm (16) . The extinction coefficient of NADPH was used for GSH-Px enzyme activity calculation. NSSA (mU/L) was measured by the method based on the nitro blue tetrazolium (NBT) reduction. One unit of NSSA was expressed as the substance amount causing 50% inhibition in the NBT reduction rate (11).
In the statistical evaluation of the results, SPSS 15.0 for Windows program was used (17).
Independent two sample t test was used to determine the differences between the groups for age, body weight and gestational weeks. Mann-Whitney U test was used to determine the differences between the groups for DS risk, MDA, GSH-Px and NSSA. In correlation analysis
Spearman test was used. P values < 0.05 were considered as significant.
RESULTS
Thirty nine pregnant women were found to be at a high risk for carrying a DS affected fetus, 9
of which were then kept out of the study according to the exclusion criteria. Study group consisted of the remaining 30 pregnant women. Control group (n=30) was randomly chosen among the DS risk negative pregnant women (n=591) after matching them to the study group for age and gestational week to eliminate the effects of these parameters on biochemical parameters.
The study and control groups consisted of 5 pregnant women between ages 18 and 25, 15
pregnant women between ages 26 and 33, and 10 pregnant women between ages 34 and 37. The distribution of NSSA values is also presented in box plot graphic in the figure 1. Correlation analyses between DS risk, test parameters and demographic data in the study and control groups are given in the table 3. MDA levels were found to increase significantly in both study and control groups with gestational week (P=0.042, r=0.37 and P<0.001, r=0.71 respectively). Over the last decades several prenatal screening programs including the quadruple test have been developed to detect pregnancies carrying DS affected fetus (1, 7, 18, 19) . Various clinical conditions including intrauterine growth retardation (IUGR), preeclampsia, gestational hypertension and gestational diabetes have been found to be associated with oxidative stress during pregnancy (20) (21) (22) . To the best of our knowledge, there is no study yet incidence is assumed to be correct, the periconceptional use of large dose folic acid and/or iron together with antioxidants might provide an opportunity for the primary prevention of DS (25) .
In the context of this literature knowledge, how can our results be evaluated? First of all, the present study is the first one investigating the association between maternal oxidant/antioxidant status and DS risk given by the prenatal screening tests. The most striking finding of the present study is that NSSA decreased significantly in the pregnant women with high risk for bearing DS fetus as compared to the controls. The decreased NSSA might indicate that the pregnant women with high risk were exposed to more oxidant stress and that consequently their antioxidant capacity was reduced. No data could be obtained in our study
for the patho-physiological mechanism(s) and/or about non-enzymatic antioxidant(s) that are responsible for the decrease in NSSA. It has been shown previously that increased oxidant stress in pregnancy is associated with several clinical conditions (20) (21) (22) . However, it is not
well-known what decreased antioxidant capacity in pregnancy indicated principally. Although decreased NSSA in the high risk group suggested an increase in oxidative stress, the observation that no difference was found in MDA levels between the groups indicated that oxidant stress did not occur severely enough to observe advanced lipid peroxidation reactions in serum. Additionally, there were no statistically significant differences in GSH-Px activities between the groups.
The decrease in NSSA in high risk group indicates that there is a reduction in nonenzymatic antioxidant capacity and this finding is consistent with that of Meguid et al (23) .
Since NSSA shows non-enzymatic antioxidant capacity, we may suggest replacing it by advising antioxidant supplementation during first trimester (23, 25) .
Another important finding of our study is that there was significant positive correlation between MDA levels and gestational week in both study and control groups (Table 3 ). This finding indicated that oxidant stress gradually increased in maternal serum during the second trimester. It is reported that pregnant women have significantly increased MDA levels according to non-pregnant women (26) . We could not compare MDA levels with nonpregnant women because we did not have a non-pregnant control group, which is a weakness in the design of this study. Additionally, significant positive correlation between MDA levels and body weight in the high risk group was observed. This finding is consistent with that of Prazny et al. who suggest that obesity may contribute, by unknown mechanism(s), to oxidant stress expressed by MDA (27) .
One of the weak points of the present study was being restricted to few oxidant and antioxidant parameters which make it difficult to evaluate the oxidant/antioxidant status completely. The scope of the study may be enriched by studying oxidation markers like 8-hydroxy-2'-Deoxyguanosine, 8-isoprostane, nitrotyrosine and antioxidant markers like thioredoxin. Another shortcoming was the lack of nutritional status of the women during pregnancy. We did not have any data about food consumption and if there was any vitamin and/or antioxidant supplementation in progress. It can be suggested that larger and more comprehensive studies may be designed to overcome these weaknesses.
In conclusion, non-enzymatic antioxidant capacity in pregnant women with a high risk of bearing a DS affected fetus decreased as compared to that of the controls. But, between the high and low risk groups there was no significant change in MDA level which is an oxidant stress marker. However, MDA level increased as gestational age increased during second trimester in the high and low risk groups. In the light of these findings, we think that it may be useful to supplement all pregnant women with antioxidant vitamins and/or foods rich in antioxidants around the time of conception possibly to prevent bearing a DS fetus.
